Statistik

Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant

Zugriffe
Modeling ...133

Gesamtzugriffe pro Monat

Januar 2026Februar 2026März 2026April 2026Mai 2026Juni 2026Juli 2026
Modeling ...0007731232

Dateiabrufe

Zugriffe
CPT Pharmacom Syst Pharma - 2024 - Kim - Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows.pdf15